Brown Advisory Inc. Cuts Stake in Establishment Labs Holdings Inc. $ESTA

Brown Advisory Inc. reduced its stake in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 8.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,994,298 shares of the company’s stock after selling 172,684 shares during the quarter. Brown Advisory Inc. owned about 6.86% of Establishment Labs worth $145,344,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also added to or reduced their stakes in the company. Goldman Sachs Group Inc. increased its stake in Establishment Labs by 117.4% in the 4th quarter. Goldman Sachs Group Inc. now owns 811,536 shares of the company’s stock worth $59,145,000 after acquiring an additional 438,206 shares during the last quarter. Viking Global Investors LP bought a new stake in Establishment Labs in the 2nd quarter worth approximately $14,669,000. Bamco Inc. NY increased its stake in Establishment Labs by 30.2% in the 3rd quarter. Bamco Inc. NY now owns 1,181,824 shares of the company’s stock worth $48,443,000 after acquiring an additional 274,287 shares during the last quarter. Soleus Capital Management L.P. bought a new stake in Establishment Labs in the 2nd quarter worth approximately $9,050,000. Finally, Summit Partners Public Asset Management LLC increased its stake in Establishment Labs by 87.1% in the 3rd quarter. Summit Partners Public Asset Management LLC now owns 430,160 shares of the company’s stock worth $17,632,000 after acquiring an additional 200,255 shares during the last quarter. 72.91% of the stock is owned by hedge funds and other institutional investors.

Establishment Labs Trading Down 3.5%

ESTA opened at $82.14 on Friday. The firm has a market cap of $2.42 billion, a price-to-earnings ratio of -55.13 and a beta of 1.11. The company has a current ratio of 2.96, a quick ratio of 1.91 and a debt-to-equity ratio of 16.82. Establishment Labs Holdings Inc. has a 12 month low of $33.35 and a 12 month high of $86.00. The stock has a fifty day moving average price of $68.81 and a 200-day moving average price of $69.17.

Establishment Labs (NASDAQ:ESTA) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.45) EPS for the quarter, missing the consensus estimate of ($0.35) by ($0.10). Establishment Labs had a negative return on equity of 218.77% and a negative net margin of 19.05%.The company had revenue of $59.88 million during the quarter, compared to the consensus estimate of $57.40 million. During the same period in the previous year, the firm posted ($0.70) earnings per share. The company’s revenue was up 44.7% on a year-over-year basis. As a group, equities research analysts anticipate that Establishment Labs Holdings Inc. will post -1.07 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have issued reports on ESTA shares. TD Cowen reaffirmed a “buy” rating on shares of Establishment Labs in a research note on Monday, June 8th. Citigroup reissued a “neutral” rating on shares of Establishment Labs in a research report on Wednesday, May 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of Establishment Labs in a research report on Friday, March 27th. Stephens boosted their price objective on Establishment Labs from $85.00 to $90.00 and gave the company an “overweight” rating in a report on Wednesday, February 25th. Finally, Wall Street Zen cut Establishment Labs from a “buy” rating to a “hold” rating in a report on Saturday, March 28th. Seven analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $87.14.

Insider Transactions at Establishment Labs

In related news, Director Quiros Juan Jose Chacon sold 105,000 shares of the company’s stock in a transaction dated Wednesday, May 6th. The stock was sold at an average price of $75.42, for a total transaction of $7,919,100.00. Following the transaction, the director directly owned 927,504 shares of the company’s stock, valued at $69,952,351.68. This represents a 10.17% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Over the last quarter, insiders sold 330,000 shares of company stock worth $22,854,538. Corporate insiders own 9.99% of the company’s stock.

Establishment Labs Company Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.